18-21006451-A-C
Position:
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The ENST00000399799.3(ROCK1):āc.1785T>Gā(p.Ser595=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00403 in 1,613,752 control chromosomes in the GnomAD database, including 29 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.0036 ( 3 hom., cov: 32)
Exomes š: 0.0041 ( 26 hom. )
Consequence
ROCK1
ENST00000399799.3 synonymous
ENST00000399799.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.292
Genes affected
ROCK1 (HGNC:10251): (Rho associated coiled-coil containing protein kinase 1) This gene encodes a protein serine/threonine kinase that is activated when bound to the GTP-bound form of Rho. The small GTPase Rho regulates formation of focal adhesions and stress fibers of fibroblasts, as well as adhesion and aggregation of platelets and lymphocytes by shuttling between the inactive GDP-bound form and the active GTP-bound form. Rho is also essential in cytokinesis and plays a role in transcriptional activation by serum response factor. This protein, a downstream effector of Rho, phosphorylates and activates LIM kinase, which in turn, phosphorylates cofilin, inhibiting its actin-depolymerizing activity. A pseudogene, related to this gene, is also located on chromosome 18. [provided by RefSeq, Aug 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.52).
BP6
Variant 18-21006451-A-C is Benign according to our data. Variant chr18-21006451-A-C is described in ClinVar as [Benign]. Clinvar id is 711996.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.292 with no splicing effect.
BS2
High AC in GnomAd4 at 542 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ROCK1 | NM_005406.3 | c.1785T>G | p.Ser595= | synonymous_variant | 16/33 | ENST00000399799.3 | NP_005397.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ROCK1 | ENST00000399799.3 | c.1785T>G | p.Ser595= | synonymous_variant | 16/33 | 1 | NM_005406.3 | ENSP00000382697 | P1 | |
ROCK1 | ENST00000635540.2 | c.1785T>G | p.Ser595= | synonymous_variant, NMD_transcript_variant | 16/34 | 5 | ENSP00000489185 |
Frequencies
GnomAD3 genomes AF: 0.00356 AC: 542AN: 152174Hom.: 3 Cov.: 32
GnomAD3 genomes
AF:
AC:
542
AN:
152174
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00360 AC: 905AN: 251156Hom.: 4 AF XY: 0.00358 AC XY: 486AN XY: 135756
GnomAD3 exomes
AF:
AC:
905
AN:
251156
Hom.:
AF XY:
AC XY:
486
AN XY:
135756
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00408 AC: 5958AN: 1461460Hom.: 26 Cov.: 31 AF XY: 0.00389 AC XY: 2827AN XY: 727030
GnomAD4 exome
AF:
AC:
5958
AN:
1461460
Hom.:
Cov.:
31
AF XY:
AC XY:
2827
AN XY:
727030
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00356 AC: 542AN: 152292Hom.: 3 Cov.: 32 AF XY: 0.00423 AC XY: 315AN XY: 74458
GnomAD4 genome
AF:
AC:
542
AN:
152292
Hom.:
Cov.:
32
AF XY:
AC XY:
315
AN XY:
74458
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 16, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at